<?xml version="1.0" encoding="UTF-8"?>
<p id="p0160">In order to accelerate innovation of treatments and vaccines to meet (unmet) medical needs for the benefit of patients, expedited review and approval pathways continue to play an important role during the COVID-19 pandemic, especially among mature agencies. For example, the EMA implemented a rolling review tool to speed up the entire review process (
 <xref rid="tbl1" ref-type="table">TableÂ I</xref>).
</p>
